Search

Author/Creator Goetz, Matthew P

1. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Issue 1 (January 2023)

Authors:
Johnston, Stephen R D; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; Huang, Chiun-Sheng; Huober, Jens; Jaliffe, Georgina Garnica; Cicin, Irfan; Tolaney, Sara M; Goetz, Matthew P; Rugo, Hope S; Senkus, Elzbieta; Testa, Laura; Del Mastro, Lucia; Shimizu, Chika...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 1(2023)
Page Start:
77
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial. (28th September 2020)

Authors:
Albain, Kathy S; Gray, Robert J; Makower, Della F; Faghih, Amir; Hayes, Daniel F; Geyer, Charles E; Dees, Elizabeth C; Goetz, Matthew P; Olson, John A; Lively, Tracy; Badve, Sunil S; Saphner, Thomas J; Wagner, Lynne I; Whelan, Timothy J; Ellis, Matthew J; Wood, William C; Keane, Maccon M; Gomez, ...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 4(2021)
Page Start:
390
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Issue 1 (January 2022)

Authors:
Yau, Christina; Osdoit, Marie; van der Noordaa, Marieke; Shad, Sonal; Wei, Jane; de Croze, Diane; Hamy, Anne-Sophie; Laé, Marick; Reyal, Fabien; Sonke, Gabe S; Steenbruggen, Tessa G; van Seijen, Maartje; Wesseling, Jelle; Martín, Miguel; del Monte-Millán, Maria; López-Tarruella, Sara; Boughey, Ju...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 1(2022)
Page Start:
149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice. Issue 5 (9th April 2020)

Authors:
Gonzalez‐Ericsson, Paula I; Stovgaard, Elisabeth S; Sua, Luz F; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O; Lænkholm, Anne‐Vibeke; Fox, Stephen B; Adam, Julien; Bartlett, John MS; Rimm, David L; Quinn, Cecily; Peeters, Dieter; Dieci, M...
Journal:
Journal of pathology
Issue:
Volume 250:Issue 5(2020)
Page Start:
667
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗